SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-019668
Filing Date
2024-07-17
Accepted
2024-07-17 16:17:53
Documents
1
Period of Report
2024-07-15

Document Format Files

Seq Description Document Type Size
1 form4-07172024_080740.html 4  
1 form4-07172024_080740.xml 4 4066
  Complete submission text file 0001415889-24-019668.txt   5483
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Issuer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 640 LEE ROAD CHESTERBROOK PA 19087
Business Address
Saik Andrew (Reporting) CIK: 0001616284 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38899 | Film No.: 241122444